"Bloodless" treatment of a Jehovah's Witness infant with ABO hemolytic disease

Lajos Lakatos, Lászlo Csáthy, E. Nemes

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

An ABO-incompatible term infant girl born to parents who are Jehovah's Witnesses was admitted to our neonatal unit with a high serum bilirubin level necessitating exchange transfusion. The parents signed a request that blood should not be administered under any circumstances. However, they authorized us to apply the possible alternative treatments of orally administered D-penicillamine (300 mg/kg per day divided in three doses for 3 days), phototherapy, intravenous fluids, and recombinant human erythropoietin (200 U/kg subcutaneously on every second day for 2 weeks). Herein, we report the outcome of this baby, who was discharged from the our unit in good condition after treatment. Her physical growth and motor milestones at 14 months of age revealed no red flags for neurodevelopmental maturation. To our knowledge, this is the first case of an infant who received such a combined alternative (and "bloodless") treatment of serious ABO hemolytic disease of the newborn.

Original languageEnglish
Pages (from-to)530-532
Number of pages3
JournalJournal of Perinatology
Volume19
Issue number7
Publication statusPublished - Oct 1999

Fingerprint

Jehovah's Witnesses
Parents
Fetal Erythroblastosis
Penicillamine
Phototherapy
Erythropoietin
Bilirubin
Therapeutics
Growth
Serum

ASJC Scopus subject areas

  • Obstetrics and Gynaecology
  • Pediatrics, Perinatology, and Child Health

Cite this

"Bloodless" treatment of a Jehovah's Witness infant with ABO hemolytic disease. / Lakatos, Lajos; Csáthy, Lászlo; Nemes, E.

In: Journal of Perinatology, Vol. 19, No. 7, 10.1999, p. 530-532.

Research output: Contribution to journalArticle

Lakatos, Lajos ; Csáthy, Lászlo ; Nemes, E. / "Bloodless" treatment of a Jehovah's Witness infant with ABO hemolytic disease. In: Journal of Perinatology. 1999 ; Vol. 19, No. 7. pp. 530-532.
@article{b69324dbb5a54474add4107c9cfcf315,
title = "{"}Bloodless{"} treatment of a Jehovah's Witness infant with ABO hemolytic disease",
abstract = "An ABO-incompatible term infant girl born to parents who are Jehovah's Witnesses was admitted to our neonatal unit with a high serum bilirubin level necessitating exchange transfusion. The parents signed a request that blood should not be administered under any circumstances. However, they authorized us to apply the possible alternative treatments of orally administered D-penicillamine (300 mg/kg per day divided in three doses for 3 days), phototherapy, intravenous fluids, and recombinant human erythropoietin (200 U/kg subcutaneously on every second day for 2 weeks). Herein, we report the outcome of this baby, who was discharged from the our unit in good condition after treatment. Her physical growth and motor milestones at 14 months of age revealed no red flags for neurodevelopmental maturation. To our knowledge, this is the first case of an infant who received such a combined alternative (and {"}bloodless{"}) treatment of serious ABO hemolytic disease of the newborn.",
author = "Lajos Lakatos and L{\'a}szlo Cs{\'a}thy and E. Nemes",
year = "1999",
month = "10",
language = "English",
volume = "19",
pages = "530--532",
journal = "Journal of Perinatology",
issn = "0743-8346",
publisher = "Nature Publishing Group",
number = "7",

}

TY - JOUR

T1 - "Bloodless" treatment of a Jehovah's Witness infant with ABO hemolytic disease

AU - Lakatos, Lajos

AU - Csáthy, Lászlo

AU - Nemes, E.

PY - 1999/10

Y1 - 1999/10

N2 - An ABO-incompatible term infant girl born to parents who are Jehovah's Witnesses was admitted to our neonatal unit with a high serum bilirubin level necessitating exchange transfusion. The parents signed a request that blood should not be administered under any circumstances. However, they authorized us to apply the possible alternative treatments of orally administered D-penicillamine (300 mg/kg per day divided in three doses for 3 days), phototherapy, intravenous fluids, and recombinant human erythropoietin (200 U/kg subcutaneously on every second day for 2 weeks). Herein, we report the outcome of this baby, who was discharged from the our unit in good condition after treatment. Her physical growth and motor milestones at 14 months of age revealed no red flags for neurodevelopmental maturation. To our knowledge, this is the first case of an infant who received such a combined alternative (and "bloodless") treatment of serious ABO hemolytic disease of the newborn.

AB - An ABO-incompatible term infant girl born to parents who are Jehovah's Witnesses was admitted to our neonatal unit with a high serum bilirubin level necessitating exchange transfusion. The parents signed a request that blood should not be administered under any circumstances. However, they authorized us to apply the possible alternative treatments of orally administered D-penicillamine (300 mg/kg per day divided in three doses for 3 days), phototherapy, intravenous fluids, and recombinant human erythropoietin (200 U/kg subcutaneously on every second day for 2 weeks). Herein, we report the outcome of this baby, who was discharged from the our unit in good condition after treatment. Her physical growth and motor milestones at 14 months of age revealed no red flags for neurodevelopmental maturation. To our knowledge, this is the first case of an infant who received such a combined alternative (and "bloodless") treatment of serious ABO hemolytic disease of the newborn.

UR - http://www.scopus.com/inward/record.url?scp=0033202314&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033202314&partnerID=8YFLogxK

M3 - Article

C2 - 10685306

AN - SCOPUS:0033202314

VL - 19

SP - 530

EP - 532

JO - Journal of Perinatology

JF - Journal of Perinatology

SN - 0743-8346

IS - 7

ER -